You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-cirrhotic

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)

Active, not recruiting
  • Chronic Hepatitis C
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Hospital de Clínicas de Porto Alegre
Aug 24, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Puerto Rico, United States (EFX, Placebo)

Active, not recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Chandler, Arizona
  • +53 more
Feb 10, 2022

Hepatocellular Carcinoma, HCC Trial in Australia, New Zealand (Abbreviated non-contrast MRI of the liver, Ultrasound

Recruiting
  • Hepatocellular Carcinoma
  • HCC
  • Abbreviated non-contrast MRI of the liver
  • +2 more
  • Camperdown, New South Wales, Australia
  • +9 more
Sep 6, 2021

Hepatitis B, HBV, Hepatitis B, Chronic Trial in Hong Kong, Sha Tin (Inarigivir soproxil, Tenofovir alafenamide fumarate (TAF))

Terminated
  • Hepatitis B
  • +2 more
  • Inarigivir soproxil
  • Tenofovir alafenamide fumarate (TAF)
  • Hong Kong, Hong Kong Island, Hong Kong
  • +1 more
Jul 20, 2020

HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

Completed
  • HCV
  • Beijing, Beijing, China
    Peking University People's hospital
Jul 25, 2020

Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
  • Riyadh, Saudi Arabia
    King Fahad Medical City
Nov 18, 2020

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in

Not yet recruiting
  • Cirrhosis
  • +2 more
  • Complete blood count
  • +2 more
  • (no location specified)
Sep 10, 2022

Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)

Completed
  • Chronic Hepatics C Virus (HCV) Genotype 1
  • +3 more
  • Beijing, China
    Beijing Tsinghua Changgung Hospital
Feb 2, 2021

Vascular Liver Disease, Portal Vein Thrombosis, Budd-Chiari Syndrome Trial in Vienna

Recruiting
  • Vascular Liver Disease
  • +5 more
    • Vienna, Austria
      Medical University of Vienna
    Oct 31, 2020

    Hepatitis B, HBV, Hepatitis B, Chronic Trial in Canada, United Kingdom (Inarigivir soproxil, Nucleoside/nucleotide (NUC)

    Terminated
    • Hepatitis B
    • +2 more
    • Inarigivir soproxil
    • Nucleoside/nucleotide (NUC) analogue inhibitors
    • Calgary, Alberta, Canada
    • +6 more
    Jul 20, 2020

    NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (HepaStem)

    Completed
    • NASH - Nonalcoholic Steatohepatitis
    • Brussels, Belgium
    • +12 more
    Oct 13, 2020

    Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis Trial in Worldwide (Cotadutide, Placebo)

    Recruiting
    • Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
    • Chandler, Arizona
    • +389 more
    Jan 16, 2023

    Clinical Course of Cirrhotic Portal Vein Thrombosis Treated With

    Recruiting
    • Portal Vein Thrombosis
    • Transjugular intrahepatic portosystemic shunt
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
    Feb 27, 2020

    Platelet Mimicking Nanoparticles in Patients With Cirrhosis

    Not yet recruiting
    • Liver Cirrhosis
    • Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.
    • Villejuif, France
      Anaesthesia unit of the Hepatobiliary Center - Paul Brousse Hosp
    Sep 18, 2023

    Hepatic Insufficiency Trial in France (Hepatobiliary scintigraphy)

    Recruiting
    • Hepatic Insufficiency
    • Hepatobiliary scintigraphy
    • Amiens, France
    • +11 more
    Nov 18, 2020

    Multiphase and Monophasic Arterial Hepatic MRI in Detection of

    Completed
    • Hepatocellular Carcinoma
    • non interventional
    • (no location specified)
    Dec 22, 2020

    Non Alcoholic Steatohepatitis (NASH) Trial in Worldwide (AXA1125, Placebo)

    Recruiting
    • Non Alcoholic Steatohepatitis (NASH)
    • Cullman, Alabama
    • +74 more
    Sep 7, 2022

    Liver Cirrhosis Trial in Sohag (stool analysis)

    Not yet recruiting
    • Liver Cirrhosis
    • stool analysis
    • Sohag, Egypt
      Sohag university hospital
    May 3, 2023

    Cirrhosis Trial in New Delhi (Carvedilol+VSL#3, Endoscopic variceal ligation)

    Completed
    • Cirrhosis
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences (ILBS)
    May 14, 2020

    Prediction of Outcome of Cirrhotic Patients at The Intensive

    Not yet recruiting
    • Liver Cirrhosis
      • (no location specified)
      Nov 2, 2023

      NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)

      Not yet recruiting
      • NAFLD Cirrhosis
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      May 5, 2023

      Muscle Cramp, Cirrhosis, Quality of Life Trial (Branched-chain Amino Acid, Placebo)

      Not yet recruiting
      • Muscle Cramp
      • +2 more
      • Branched-chain Amino Acid
      • Placebo
      • (no location specified)
      Feb 9, 2023

      Decompensated Cirrhosis and Ascites Trial in Bangkok (Branched-chain amino acid)

      Recruiting
      • Decompensated Cirrhosis and Ascites
      • Branched-chain amino acid
      • Bangkok, Thailand
        Division of Gastroenterology, Department of Medicine, Faculty of
      Nov 13, 2023

      Hemorrhoids, Liver Cirrhosis Trial in Porto (Polidocanol foam sclerotherapy)

      Recruiting
      • Hemorrhoids
      • Liver Cirrhosis
      • Polidocanol foam sclerotherapy
      • Porto, Portugal
        Centro Hospitalar Universitário do Porto
      Apr 6, 2023

      Liver Disease Chronic, Hepatitis B Virus Trial in Terrassa (Fendrix or HBVAXPRO 40)

      Completed
      • Liver Disease Chronic
      • Hepatitis B Virus
      • Fendrix or HBVAXPRO 40
      • Terrassa, Barcelona/Spain, Spain
        Hospital Universitari Mutua Terrassa
      Jul 7, 2022